FGF-2 targets sclerostin in bone and myostatin in skeletal muscle to mitigate the deleterious effects of glucocorticoid on musculoskeletal degradation

Authors:

Abstract
No abstract available
Funding Information
  • University Grants Commission
  • Central Mechanical Engineering Research Institute, Council of Scientific and Industrial Research

This publication has 59 references indexed in Scilit: